Cardiogenic Shock Working Group Registry

Launched by TUFTS MEDICAL CENTER · Dec 22, 2020

Keywords

ClinConnect Summary

The Cardiogenic Shock Working Group Registry is a clinical trial that aims to gather and analyze information about patients experiencing cardiogenic shock, a serious condition where the heart cannot pump enough blood to meet the body's needs. Researchers will collect data from patients’ medical records and follow-up phone calls from multiple hospitals to better understand the outcomes of this condition and improve future treatments.

To be eligible for this study, participants must be diagnosed with cardiogenic shock, which can be identified by specific medical signs or the need for special devices to help support their heart function. The trial is open to all patients aged 65 and older. If you or a loved one is interested in participating, you can expect to have your health information reviewed and followed up on, but your personal details will remain confidential. This registry is important because it will help researchers learn more about cardiogenic shock and potentially improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must have cardiogenic shock.
• Cardiogenic shock is defined by at least one of the two categories below:
• 1. At least 2 of the following concurrently at any point during the index hospitalization:
• • Cardiac Index \< 2.2
• • PAPI \< 1.0
• • Cardiac Power Output ≤ 0.6
• • MAP \< 60mmHg or a \>30mmHg drop in MAP from baseline
• • SBP \< 90mmHg or a \>30mmHg drop in SBP from baseline
• • Pulse \> 100
• • 2. Require at least one acute mechanical circulatory support device, vasopressor or inotrope to maintain values above the above target.
• • Post-cardiotomy patients must meet the inclusion criteria 72 hours after their surgery to be included in this registry.